566 filings
DEFA14A
NGNE
Neurogene Inc
26 Apr 24
Additional proxy soliciting materials
2:34pm
ARS
2023 FY
NGNE
Neurogene Inc
26 Apr 24
Annual report to shareholders
2:33pm
DEF 14A
NGNE
Neurogene Inc
Definitive proxy
26 Apr 24
2:33pm
8-K
NGNE
Neurogene Inc
24 Apr 24
Departure of Directors or Certain Officers
5:47pm
8-K
NGNE
Neurogene Inc
22 Apr 24
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
4:44pm
8-K
NGNE
Neurogene Inc
2 Apr 24
Departure of Directors or Certain Officers
3:43pm
8-K
NGNE
Neurogene Inc
18 Mar 24
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
4:10pm
10-K
2023 FY
NGNE
Neurogene Inc
Annual report
18 Mar 24
4:04pm
4
NGNE
Neurogene Inc
14 Mar 24
Neurogene / Rachel McMinn ownership change
8:54pm
4
Christine Mikail Cvijic
14 Mar 24
Neurogene / Christine Mikail Cvijic ownership change
8:53pm
4
Stuart Cobb
14 Mar 24
Neurogene / Stuart Cobb ownership change
8:51pm
144
NGNE
Neurogene Inc
7 Mar 24
Notice of proposed sale of securities
4:29pm
144
Sean Michael Smith
4 Mar 24
Notice of proposed sale of securities
6:20pm
8-K
NGNE
Neurogene Inc
4 Mar 24
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett
7:30am
8-K
NGNE
Neurogene Inc
21 Feb 24
Departure of Directors or Certain Officers
4:07pm
S-8
NGNE
Neurogene Inc
20 Feb 24
Registration of securities for employees
4:16pm
SC 13G
EcoR1 Capital, LLC
14 Feb 24
Neurogene / EcoR1 Capital ownership change
6:05pm
SC 13G/A
NGNE
Neurogene Inc
14 Feb 24
Neurogene / GREAT POINT PARTNERS ownership change
4:37pm
SC 13G/A
Redmile Group, LLC
14 Feb 24
Neurogene / Redmile ownership change
4:26pm
SC 13G
Samsara BioCapital, L.P.
14 Feb 24
Neurogene / Samsara BioCapital ownership change
4:16pm